| Dr Amber Chambers, MD | |
|
484 Golden Autumn Way Ste 201, Bowling Green, KY 42103-6913 | |
| (270) 393-2778 | |
| (270) 783-3742 |
| Full Name | Dr Amber Chambers |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 19 Years |
| Location | 484 Golden Autumn Way Ste 201, Bowling Green, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790097111 | NPI | - | NPPES |
| 000000671202 | Other | KY | ANTHEM |
| 7100124350 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | TP228 (Kentucky) | Secondary |
| 208600000X | Surgery | 43669 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Medical Center (bowling Green) | Bowling green, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gilbert Barbee Moore And Mcilvoy Psc | 4082511167 | 223 |
| Commonwealth Health Corporation Inc | 5496667628 | 221 |
News Archive
The Stem Cells and Cancer Research Group headed by Dr H-ctor G. Palmer at the Vall d'Hebr-n Institute of Oncology (VHIO) has identified the molecular mechanisms that determine patients' response to certain drugs used in clinical trials for colon cancer treatment. The study led by VHIO also benefited from the collaboration with Professor Alberto Mu-oz-s laboratory at the Instituto de Investigaciones Biomedicas Alberto Sols, Consejo Superior de Investigaciones Cient-ficas.
Scientists have cracked the genetic code and predicted some high priority drug targets for the blood parasite Schistosoma haematobium, which is linked to bladder cancer and HIV/ AIDS and causes the insidious urogenital disease schistosomiasis haematobia in more than 112 million people in Africa.
Evidence continues to mount that vaccination against COVID-19, most notably the Pfizer and Moderna vaccines, produces robust, durable protection in the vast majority of recipients.
The anti-inflammatory class of drugs NSAIDs have shown great promise in preventing cancers including colon, esophagus and skin. However, they can increase the risks of heart attacks, ulcers and rare but potentially life-threatening bleeds.
› Verified 4 days ago
| Entity Name | Gilbert Barbee Moore & Mcilvoy Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114948288 PECOS PAC ID: 4082511167 Enrollment ID: O20031217000136 |
News Archive
The Stem Cells and Cancer Research Group headed by Dr H-ctor G. Palmer at the Vall d'Hebr-n Institute of Oncology (VHIO) has identified the molecular mechanisms that determine patients' response to certain drugs used in clinical trials for colon cancer treatment. The study led by VHIO also benefited from the collaboration with Professor Alberto Mu-oz-s laboratory at the Instituto de Investigaciones Biomedicas Alberto Sols, Consejo Superior de Investigaciones Cient-ficas.
Scientists have cracked the genetic code and predicted some high priority drug targets for the blood parasite Schistosoma haematobium, which is linked to bladder cancer and HIV/ AIDS and causes the insidious urogenital disease schistosomiasis haematobia in more than 112 million people in Africa.
Evidence continues to mount that vaccination against COVID-19, most notably the Pfizer and Moderna vaccines, produces robust, durable protection in the vast majority of recipients.
The anti-inflammatory class of drugs NSAIDs have shown great promise in preventing cancers including colon, esophagus and skin. However, they can increase the risks of heart attacks, ulcers and rare but potentially life-threatening bleeds.
› Verified 4 days ago
| Entity Name | Commonwealth Health Corporation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881109304 PECOS PAC ID: 5496667628 Enrollment ID: O20040916000800 |
News Archive
The Stem Cells and Cancer Research Group headed by Dr H-ctor G. Palmer at the Vall d'Hebr-n Institute of Oncology (VHIO) has identified the molecular mechanisms that determine patients' response to certain drugs used in clinical trials for colon cancer treatment. The study led by VHIO also benefited from the collaboration with Professor Alberto Mu-oz-s laboratory at the Instituto de Investigaciones Biomedicas Alberto Sols, Consejo Superior de Investigaciones Cient-ficas.
Scientists have cracked the genetic code and predicted some high priority drug targets for the blood parasite Schistosoma haematobium, which is linked to bladder cancer and HIV/ AIDS and causes the insidious urogenital disease schistosomiasis haematobia in more than 112 million people in Africa.
Evidence continues to mount that vaccination against COVID-19, most notably the Pfizer and Moderna vaccines, produces robust, durable protection in the vast majority of recipients.
The anti-inflammatory class of drugs NSAIDs have shown great promise in preventing cancers including colon, esophagus and skin. However, they can increase the risks of heart attacks, ulcers and rare but potentially life-threatening bleeds.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amber Chambers, MD 201 Park St, Bowling Green, KY 42101-1759 Ph: (270) 781-5111 | Dr Amber Chambers, MD 484 Golden Autumn Way Ste 201, Bowling Green, KY 42103-6913 Ph: (270) 393-2778 |
News Archive
The Stem Cells and Cancer Research Group headed by Dr H-ctor G. Palmer at the Vall d'Hebr-n Institute of Oncology (VHIO) has identified the molecular mechanisms that determine patients' response to certain drugs used in clinical trials for colon cancer treatment. The study led by VHIO also benefited from the collaboration with Professor Alberto Mu-oz-s laboratory at the Instituto de Investigaciones Biomedicas Alberto Sols, Consejo Superior de Investigaciones Cient-ficas.
Scientists have cracked the genetic code and predicted some high priority drug targets for the blood parasite Schistosoma haematobium, which is linked to bladder cancer and HIV/ AIDS and causes the insidious urogenital disease schistosomiasis haematobia in more than 112 million people in Africa.
Evidence continues to mount that vaccination against COVID-19, most notably the Pfizer and Moderna vaccines, produces robust, durable protection in the vast majority of recipients.
The anti-inflammatory class of drugs NSAIDs have shown great promise in preventing cancers including colon, esophagus and skin. However, they can increase the risks of heart attacks, ulcers and rare but potentially life-threatening bleeds.
› Verified 4 days ago
Dr. Shane Damien O'keeffe, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 350 Park St, Suite 210, Bowling Green, KY 42101 Phone: 270-796-3330 Fax: 270-796-3338 | |
Salim C Saba, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 141 Mooreborough Ct, Bowling Green, KY 42103 Phone: 929-255-6856 | |
Dr. Mark D. Jessen, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1326 Andrea St, Bowling Green, KY 42104 Phone: 270-781-1588 Fax: 270-781-1598 | |
Fouad Victor Atalla, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1048 Ashley St Ste 303, Bowling Green, KY 42103 Phone: 270-796-8960 Fax: 270-842-5683 | |
Dr. Chen Rubinstein, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: Cardiac Surgery Of South Central Ky, 350 Park St Suite 210, Bowling Green, KY 42101 Phone: 270-796-3330 Fax: 270-796-3338 | |
Dr. George Wayne Bush, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1325 Andrea St, Suite 209, Bowling Green, KY 42104 Phone: 270-842-1660 | |
Dr. Timothy Wierson, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 484 Golden Autumn Way Ste 201, Bowling Green, KY 42103 Phone: 270-783-3340 Fax: 270-780-0492 |